New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 ...

Sir, Patients with neurofibromatosis type 2 (NF-2), a rare autosomal dominant disease caused by mutations in the NF-2 tumour-suppressor gene on chromosome 22q12, 1 are predisposed to central ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Mandal, Ananya. (2022, December 31). Neurofibromatosis Type 2 Management.

Atypical manifestation of neurofibromatosis type 2 (NF2) in a 10-year-old boy was recently reported in Eye. 1 I would like to present another 10-year-old child with the atypical presentation of ...

Neurofibromatosis type 2 is a dominantly inherited genetic condition with a birth prevalence of 1 in 25,000. 1 Bilateral vestibular schwannomas (also known as acoustic neuromas), which are benign ...

A new study co-led by Mass General Brigham researchers points to a promising new type of auditory brainstem implant (ABI) that could benefit people who are deaf due to Neurofibromatosis type 2 ...

In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...

New auditory brainstem implant shows early promise Date: May 16, 2025 Source: Mass Eye and Ear Summary: Investigators are developing a new type of auditory brainstem implant that is designed to be ...